Immunology

Items 1651-1660 of 4356

per page
Set Descending Direction
  1. anti-Ki-67 (human), Rabbit Monoclonal (RM521)
    REV-31-1413-00
    REV-31-1413-00-R100100 µl
    CHF 468.00
    anti-Ki-67 (human), Rabbit Monoclonal (RM521)
  2. anti-KI67 (human), Rabbit Monoclonal (RM360)
    REV-31-1246-00
    REV-31-1246-00-R100100 µl
    CHF 459.00
    Immunohistochemical staining of formalin fixed and paraffin embedded human tonsil tissue sections, using anti-Ki-67 Rabbit Monoclonal Antibody (Clone RM360) at a 1:1000 dilution.
  3. anti-LAG-3 (human), mAb (17B4) (ATTO 488)
    AG-20B-0012TD
    AG-20B-0012TD-T100100 tests
    CHF 490.00
    Detection of endogenous human LAG-3 by FACS analysis using anti-LAG-3 (human), mAb (17B4) (ATTO 488) (Prod. No. AG-20B-0012TD). 
Human PBMC were stimulated (B) or not (A) with 1μg/ml of superantigen SEB. After 2 days, PBMC were stained with 10&mu
  4. anti-LAG-3 (human), mAb (17B4) (ATTO 590)
    AG-20B-0012TM
    AG-20B-0012TM-T100100 tests
    CHF 490.00
  5. anti-LAG-3 (human), mAb (17B4) (ATTO 647N)
    AG-20B-0012TS
    AG-20B-0012TS-T100100 tests
    CHF 490.00
    Detection of endogenous human LAG-3 by FACS analysis using anti-LAG-3 (human), mAb (17B4) (ATTO 647) (Prod. No. AG-20B-0012TS).
Human PBMC were stimulated (B) or not (A) with 1μg/ml of superantigen SEB. After 2 days PBMC were stained with 10μg
  6. anti-LAG-3 (human), mAb (17B4) (Biotin)
    AG-20B-0012B
    AG-20B-0012B-C100100 µg
    CHF 440.00
  7. anti-LAG-3 (human), mAb (17B4) (FITC)
    AG-20B-0012F
    AG-20B-0012F-C100100 µg
    CHF 480.00
  8. anti-LAG-3 (human), mAb (blocking) (17B4)
    AG-20B-0012
    AG-20B-0012-C100100 µg
    CHF 470.00
  9. anti-LAG-3 (human), mAb (blocking) (17B4) (preservative free)
    AG-20B-0012PF
    AG-20B-0012PF-C100100 µg
    CHF 470.00
    AG-20B-0012PF-C500500 µg
    CHF 1'880.00
  10. anti-LAG-3, mAb (blocking) (11E3)
    AG-20B-0011
    AG-20B-0011-C100100 µg
    CHF 470.00

Items 1651-1660 of 4356

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.